Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathology

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kam, Korey ^a,b   Duffy, Áine M ^a,b   Moretto, Jillian ^a   LaFrancois, John J ^a   Scharfman, Helen E ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; MUSCARINIC RECEPTOR; PROTEIN C FOS;

ACTION POTENTIAL; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; FEMALE; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; REM SLEEP; SLEEP; TRANSGENIC MOUSE;

ACTION POTENTIALS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN WAVES; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; FEMALE; MALE; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, MUSCARINIC; SLEEP; SLEEP, REM;

EID: 84961371640     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20119     Document Type: Article

References (81)

1. Sperling, R. A., Jack, C. R. Jr. & Aisen, P. S. Testing the right target and right drug at the right stage. Sci Transl Med 3, 111 (2011).
2. Palop, J. J. & Mucke, L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66, 435-440 (2009).
3. Noebels, J. A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia 52 Suppl 1, 39-46 (2011).
4. Friedman, D., Honig, L. S. & Scarmeas, N. Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther 18, 285-294 (2012).
5. Bakker, A. et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 74, 467-474 (2012).
6. Sanchez, P. E. et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci USA 109, E2895-2903 (2012).
7. Scharfman, H. E. "Untangling" Alzheimer's disease and epilepsy. Epilepsy Curr 12, 178-183 (2012).
8. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
9. Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672-674 (1992).
10. Ashe, K. H. & Zahs, K. R. Probing the biology of Alzheimer's disease in mice. Neuron 66, 631-645 (2010).
11. Kawarabayashi, T. et al. Age-dependent changes in brain, CSF, and plasma amyloid (β) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21, 372-381 (2001).
12. Jacobsen, J. S. et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 103, 5161-5166 (2006).
13. Prince, D. A. & Connors, B. W. Mechanisms of interictal epileptogenesis. Adv Neurol 44, 275-299 (1986).
14. Bezzina, C. et al. Early onset of hypersynchronous network activity and expression of a marker of chronic seizures in the Tg2576 mouse model of Alzheimer's disease. PLoS One 10, e0119910 (2015).
15. Wesson, D. W., Levy, E., Nixon, R. A. & Wilson, D. A. Olfactory dysfunction correlates with amyloid-β burden in an Alzheimer's disease mouse model. J Neurosci 30, 505-514 (2010).
16. Duffy, A. M. et al. Entorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age. Neurobiol Aging 36, 134-148 (2015).
17. Iyengar, S. S. et al. Suppression of adult neurogenesis increases the acute effects of kainic acid. Exp Neurol 264, 135-149 (2015).
18. Zhang, B. et al. Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons. Am J Pathol 167, 1361-1369 (2005).
19. Wisor, J. P. et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: A role for cholinergic transmission. Neuroscience 131, 375-385 (2005).
20. Born, H. A. et al. Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzheimer's disease. J Neurosci 34, 3826-3840 (2014).
21. Herzig, M. C. et al. Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7, 954-960 (2004).
22. McCarley, R. W. Neurobiology of REM and NREM sleep. Sleep Med 8, 302-330 (2007).
23. Turski, W. A. et al. Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study. Behav Brain Res 9, 315-335 (1983).
24. Zimmerman, G. et al. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. Eur J Neurosci 27, 965-975 (2008).
25. Bartus, R. T., Dean, R. L., Beer, B. & Lippa, A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414 (1982).
26. Jasper, H. H. & Tessier, J. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science 172, 601-602 (1971).
27. Vazquez, J. & Baghdoyan, H. A. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. Am J Physiol Regul Integr Comp Physiol 280, R598-601 (2001).
28. Zhang, H., Lin, S. C. & Nicolelis, M. A. Spatiotemporal coupling between hippocampal acetylcholine release and theta oscillations in vivo. J Neurosci 30, 13431-13440 (2010).
29. Buzsáki, G. Theta oscillations in the hippocampus. Neuron 33, 325-340 (2002).
30. Apelt, J., Kumar, A. & Schliebs, R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the swedish mutation of human β-amyloid precursor protein. Brain Res 953, 17-30 (2002).
31. Zaborszky, L., van den Pol, A. & Gyengesi, E. The basal forebrain cholinergic projection system in mice. The Mouse Nervous System 28, 684-718 (2012).
32. Vann, S. D., Aggleton, J. P. & Maguire, E. A. What does the retrosplenial cortex do? Nat Rev Neurosci 10, 792-802 (2009).
33. Lithfous, S., Dufour, A. & Despres, O. Spatial navigation in normal aging and the prodromal stage of Alzheimer's disease: Insights from imaging and behavioral studies. Ageing Res Rev 12, 201-213 (2013).
34. Murakami, K., Ishikawa, Y. & Sato, F. Localization of α7 nicotinic acetylcholine receptor immunoreactivity on GABAergic interneurons in layers 1-3 of the rat retrosplenial granular cortex. Neuroscience 252, 443-459 (2013).
35. Robertson, R. T., Baratta, J., Yu, J. & LaFerla, F. M. Amyloid-β expression in retrosplenial cortex of triple transgenic mice: Relationship to cholinergic axonal afferents from medial septum. Neuroscience 164, 1334-1346 (2009).
36. Arnaud, C., Gauthier, P. & Gottesmann, C. Atropine effects on the intermediate stage and paradoxical sleep in rats. Psychopharmacology 116, 304-308 (1994).
37. Mavanji, V. & Datta, S. Sleep-wake effects of yohimbine and atropine in rats with a clomipramine-based model of depression. Neuroreport 13, 1603-1606 (2002).
38. Verret, L. et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708-721 (2012).
39. Cavanagh, C. et al. βCTF-correlated burst of hippocampal TNFα occurs at a very early, pre-plaque stage in the TgCRND8 mouse model of Alzheimer's disease. J Alzheimers Dis 36, 233-238 (2013).
40. Xu, W., Fitzgerald, S., Nixon, R. A., Levy, E. & Wilson, D. A. Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease. Exp Neurol 264, 82-91 (2015).
41. Heinemann, U., Kann, O. & Schuchmann, S. An overview of in vitro seizure models in acute and organotypic slices. In: Models of seizures and epilepsy. Pitkänen, A., Schwartzkroin, P. A., Moshé, S. L. Elsevier (2006).
42. Cao, L. et al. Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 3, 1009 (2012).
43. Bero, A. et al. Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nature Neurosci 14, 750-756 (2011).
44. Busche, M. A. et al. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 109, 8740-8745 (2012).
45. Vossel, K. A. et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol 70, 1158-1166 (2013).
46. Scala, F. et al. Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3. Neurobiol Aging 36, 886-900 (2015).
47. Puzzo, D. et al. Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28, 14537-14545 (2008).
48. Busche, M. A. et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321, 1686-1689 (2008).
49. Palop, J. J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697-711 (2007).
50. Zheng, W. H., Bastianetto, S., Mennicken, F., Ma, W. & Kar, S. Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115, 201-211 (2002).
51. Hu, L., Wong, T. P., Cote, S. L., Bell, K. F. & Cuello, A. C. The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in Alzheimer's disease-like transgenic mice. Neuroscience 121, 421-432 (2003).
52. Kar, S., Slowikowski, S. P. M. & Westaway, D.. Mount HTJ. Interactions between β-amyloid and central cholinergic neurons: Implications for Alzheimer's disease. J Psychiatry Neurosci 29, 427-441 (2004).
53. Luth, H. J., Apelt, J., Ihunwo, A. O., Arendt, T. & Schliebs, R. Degeneration of β-amyloid-associated cholinergic structures in transgenic APP-sw mice. Brain Res 977, 16-22 (2003).
54. Kuznetsova, E. & Schliebs, R. β-amyloid, cholinergic transmission, and cerebrovascular system - a developmental study in a mouse model of Alzheimer's disease. Curr Pharm Design 19, 6749-6765 (2013).
55. Kuo, J. J. et al. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J Neurophysiol 91, 571-575 (2004).
56. Vucic, S. & Kiernan, M. C. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 129, 2436-2446 (2006).
57. Gutnick, M. J., Connors, B. W. & Prince, D. A. Mechanisms of neocortical epileptogenesis in vitro. J Neurophysiol 48, 1321-1335 (1982).
58. Dyhrfjeld-Johnsen, J., Berdichevsky, Y., Swiercz, W., Sabolek, H. & Staley, K. J. Interictal spikes precede ictal discharges in an organotypic hippocampal slice culture model of epileptogenesis. J Clin Neurophysiol 27, 418-424 (2010).
59. Chauviere, L. et al. Changes in interictal spike features precede the onset of temporal lobe epilepsy. Ann Neurol 71, 805-814 (2012).
60. Staley, K. J. & Dudek, F. E. Interictal spikes and epileptogenesis. Epilepsy Curr 6, 199-202 (2006).
61. Kleen, J. K., Scott, R. C., Holmes, G. L. & Lenck-Santini, P. P. Hippocampal interictal spikes disrupt cognition in rats. Ann Neurol 67, 250-257 (2010).
62. Kleen, J. K. et al. Hippocampal interictal epileptiform activity disrupts cognition in humans. Neurology 81, 18-24 (2013).
63. Buzsáki, G. Two-stage model of memory trace formation: A role for "noisy" brain states. Neuroscience 31, 551-570 (1989).
64. Wilson, M. A. & McNaughton, B. L. Reactivation of hippocampal ensemble memories during sleep. Science 265, 676-679 (1994).
65. Kang, J. E. et al. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007 (2009).
66. Xie, L. et al. Sleep drives metabolite clearance from the adult brain. Science 342, 373-377 (2013).
67. Roh, J. H. et al. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 4, 150ra122 (2012).
68. Cirrito, J. R. et al. Synaptic activity regulates interstitial fluid amyloid-β levels in vivo. Neuron 48, 913-922 (2005).
69. Oostenveld, R., Fries, P., Maris, E. & Schoffelen, J. M. Fieldtrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci 2011, 156869 (2011).
70. Brankack, J., Kukushka, V. I., Vyssotski, A. L. & Draguhn, A. EEG gamma frequency and sleep-wake scoring in mice: Comparing two types of supervised classifiers. Brain Res 1322, 59-71 (2010).
71. Csicsvari, J., Hirase, H., Czurko, A. & Buzsáki, G. Reliability and state dependence of pyramidal cell-interneuron synapses in the hippocampus: An ensemble approach in the behaving rat. Neuron 21, 179-189 (1998).
72. Breiman, L. Random forests. Machine Learning 45, 5-32 (2001).
73. Haba-Rubio, J., Ibanez, V. & Sforza, E. An alternative measure of sleep fragmentation in clinical practice: The sleep fragmentation index. Sleep medicine 5, 577-581 (2004).
74. Racine, R. J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32, 281-294 (1972).
75. Oda, Y., Nakanishi, I. & Deguchi, T. A complementary DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells. Brain Res Mol Brain Res 16, 287-294 (1992).
76. Duffy, A. M., Schaner, M. J., Chin, J. & Scharfman, H. E. Expression of c-fos in hilar mossy cells of the dentate gyrus in vivo. Hippocampus 23, 649-655 (2013).
77. Buzsáki, G., Czopf, J., Kondakor, I. & Kellenyi, L. Laminar distribution of hippocampal rhythmic slow activity (RSA) in the behaving rat: Current-source density analysis, effects of urethane and atropine. Brain Res 365, 125-137 (1986).
78. Leung, L. S., Martin, L. A. & Stewart, D. J. Hippocampal theta rhythm in behaving rats following ibotenic acid lesion of the septum. Hippocampus 4, 136-147 (1994).
79. Dobelis, P., Hutton, S., Lu, Y. & Collins, A. C. GABAergic systems modulate nicotinic receptor-mediated seizures in mice. J Pharmacol Exp Ther 306, 1159-1166 (2003).
80. Damaj, M. I., Glassco, W., Dukat, M. & Martin, B. R. Pharmacological characterization of nicotine-induced seizures in mice. J Pharmacol Exp Ther 291, 1284-1291 (1999).
81. Dong, H., Yuede, C. M., Coughlan, C. A., Murphy, K. M. & Csernansky, J. G. Effects of donepezil on amyloid-β and synapse density in the Tg2576 mouse model of Alzheimer's disease. Brain Res 1303, 169-178 (2009).